| Literature DB >> 35010730 |
Ángela Sánchez-Gómez1, Jose Manuel Jurado-Castro2,3, Fernando Mata4, Antonio Jesús Sánchez-Oliver5,6, Raúl Domínguez5,6.
Abstract
The aim of the present study was to analyze the effect of conservative non-invasive treatments based on eccentric training, stretching and extracorporeal shock wave therapy (ESWT) supplemented with β-Hydroxy β-methylbutyric (HMB) or placebo (PLAC) on body composition, pain and muscular function (jump ability, muscular power and muscular strength) in athletes with patellar tendinopathy (PT). In a double-blind randomized trial, 8 athletes (4 males and 4 females) performed a physical rehabilitation for 4 weeks. They were randomly divided into two experimental groups (two males and two females in each one) that ingested HMB (HMBG) or PLAC (PLACG). In pre- and post-intervention were assessed body composition, pain, countermovement jump (CMJ), back-squat (BS) for analyzing peak power (W) (PPPP), load (kg) associated to PPPP (PPKG) and mean velocity (m/s) (PPMV) in addition to a 5-RM leg extension tests. An interaction intervention·supplementation (p = 0.049; Ƞ2p = 0.774) was observed in the height reached in the CMJ as an intervention effect in PPPP detected for the HMBG (p = 0.049). In addition, an enhancement in PPKG (p = 0.028; Ƞ2p = 0.842) was detected in the intervention, but not in PPMV, as an increase in the intervention in the 5-RM test (p = 0.001; Ƞ2p = 0.981) was observed. No changes were noted on body composition or pain (p > 0.05). The combination of eccentric training with stretching and ESWT increased concentric muscular power and strength after 4 weeks without changes in body lean mass or pain. In addition, HMB supplementation could enhance the power muscular performance in athletes with PT, optimizing the intervention adaptions.Entities:
Keywords: injury; patellar tendinopathy; recovery; rehabilitation; sport nutrition; supplement
Mesh:
Year: 2022 PMID: 35010730 PMCID: PMC8744953 DOI: 10.3390/ijerph19010471
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Experimental design.
Anthropometric variables result.
| Variable | Supplementation | Intervention | ||||
|---|---|---|---|---|---|---|
| PRE | POST | |||||
| Body mass | HMBG | 79.7 ± 9.3 | 80.3 ± 10.7 | 0.950 | 0.924 | 0.456 |
| PLACG | 79.5 ± 7.3 | 78.8 ± 8.4 | ||||
| BMI | HMBG | 24.3 ± 2.7 | 25.1 ± 2.1 | 0.387 | 0.927 | 0.367 |
| PLACG | 24.9 ± 1.9 | 24.7 ± 2.1 | ||||
| Body fat | HMBG | 13.9 ± 7.2 | 14.8 ± 6.9 | 0.223 | 0.984 | 0.168 |
| PLACG | 18.2 ± 5.6 | 18.6 ± 5.4 | ||||
| %Body | HMBG | 18.2 ± 11.0 | 18.9 ± 10.0 | 0.160 | 0.876 | 0.371 |
| PLACG | 22.8 ± 7.0 | 23.6 ± 7.0 | ||||
| Body muscle | HMBG | 63.3 ± 14.3 | 62.2 ± 13.1 | 0.460 | 0.621 | 0.277 |
| PLACG | 57.8 ± 7.9 | 57.7 ± 7.1 | ||||
| %Body | HMBG | 77.7 ± 10.6 | 77.1 ± 9.8 | 0.710 | 0.544 | 0.888 |
| PLACG | 73.1 ± 7.0 | 72.8 ± 6.4 | ||||
Data presented as M ± SD. BMI: body mass index; HMBG: β-Hydroxy β-methylbutyric group; PLACG: placebo group.
Figure 2Subjective pain perceived by the VISA-P score.
Performance variables in the CMJ, BS incremental test and 5-RM test.
| Variable | Supplementation | Intervention | ||||
|---|---|---|---|---|---|---|
| PRE | POST | |||||
| CMJ (cm) | HMBG | 38.1 ± 10.4 | 41.1 ± 11.7 | 0.850 | 0.694 | 0.049λ |
| PLACG | 37.0 ± 6.0 | 35.6 ± 4.7 | ||||
| PPKG (kg) | HMBG | 59.4 ± 13.0 | 71.5 ± 17.0 | 0.028 * | 0.948 | 0.335 |
| PLACG | 65.0 ± 17.8 | 64.4 ± 11.6 | ||||
| PPMV (m·s−1) | HMBG | 0.78 ± 0.12 | 0.81 ± 0.05 | 0.296 | 0.268 | 0.796 |
| PLACG | 0.74 ± 0.04 | 0.79 ± 0.03 | ||||
| PPPP (W) | HMBG | 455.5 ± 105.5 # | 575.3 ± 138.8 | 0.002 * | 0.842 | 0.142 |
| PLACG | 479.0 ± 125.3 | 514.4 ± 107.0 | ||||
| 5-RM test (kg) | HMBG | 55.0 ± 4.1 # | 68.1 ± 3.1 | 0.001 * | 0.081 | 0.184 |
| PLACG | 73.8 ± 10.5 # | 80.0 ± 9.4 | ||||
Data presented as M ± SD. BS: back squat; CMJ: countermovement jump; HMBG: β-Hydroxy β-methylbutyric group; PLACG: placebo group; PPKG: peak power kg lifted; PPMV: peak power mean velocity; PPPP: peak power; 5-RM: five-repetition maximum; #: significant effect of a group in the post-intervention vs pre-intervention; *: significant effect for intervention; λ: significant effect for intervention·supplementation.